These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

642 related items for PubMed ID: 8636377

  • 1. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
    Romei C, Elisei R, Pinchera A, Ceccherini I, Molinaro E, Mancusi F, Martino E, Romeo G, Pacini F.
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
    [Abstract] [Full Text] [Related]

  • 2. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.
    Marsh DJ, Learoyd DL, Andrew SD, Krishnan L, Pojer R, Richardson AL, Delbridge L, Eng C, Robinson BG.
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):249-57. PubMed ID: 8729519
    [Abstract] [Full Text] [Related]

  • 3. Molecular analysis of the RET proto-oncogene in patients with sporadic medullary thyroid carcinoma: a novel point mutation in the extracellular cysteine-rich domain.
    Bugalho MJ, Frade JP, Santos JR, Limbert E, Sobrinho L.
    Eur J Endocrinol; 1997 Apr; 136(4):423-6. PubMed ID: 9150704
    [Abstract] [Full Text] [Related]

  • 4. Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas.
    Komminoth P, Kunz EK, Matias-Guiu X, Hiort O, Christiansen G, Colomer A, Roth J, Heitz PU.
    Cancer; 1995 Aug 01; 76(3):479-89. PubMed ID: 8625130
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. RET protooncogene mutations in patients with apparently sporadic medullary thyroid carcinoma.
    Huang CN, Wu SL, Chang TC, Huang SH, Chang TJ.
    J Formos Med Assoc; 1998 Aug 01; 97(8):541-6. PubMed ID: 9747064
    [Abstract] [Full Text] [Related]

  • 7. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P.
    Verh Dtsch Ges Pathol; 1995 Aug 01; 79():L-LV. PubMed ID: 8600671
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.
    Zedenius J, Wallin G, Hamberger B, Nordenskjöld M, Weber G, Larsson C.
    Hum Mol Genet; 1994 Aug 01; 3(8):1259-62. PubMed ID: 7987299
    [Abstract] [Full Text] [Related]

  • 11. Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas.
    Uchino S, Noguchi S, Adachi M, Sato M, Yamashita H, Watanabe S, Murakami T, Toda M, Murakami N, Yamashita H.
    Jpn J Cancer Res; 1998 Apr 01; 89(4):411-8. PubMed ID: 9617347
    [Abstract] [Full Text] [Related]

  • 12. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
    Fink M, Weinhüsel A, Niederle B, Haas OA.
    Int J Cancer; 1996 Aug 22; 69(4):312-6. PubMed ID: 8797874
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma.
    Shirahama S, Ogura K, Takami H, Ito K, Tohsen T, Miyauchi A, Nakamura Y.
    J Hum Genet; 1998 Aug 22; 43(2):101-6. PubMed ID: 9621513
    [Abstract] [Full Text] [Related]

  • 15. Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas.
    Zedenius J, Larsson C, Bergholm U, Bovée J, Svensson A, Hallengren B, Grimelius L, Bäckdahl M, Weber G, Wallin G.
    J Clin Endocrinol Metab; 1995 Oct 22; 80(10):3088-90. PubMed ID: 7559902
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma.
    Wohllk N, Cote GJ, Bugalho MM, Ordonez N, Evans DB, Goepfert H, Khorana S, Schultz P, Richards CS, Gagel RF.
    J Clin Endocrinol Metab; 1996 Oct 22; 81(10):3740-5. PubMed ID: 8855832
    [Abstract] [Full Text] [Related]

  • 18. The newly detected mutations in the RET proto-oncogene in exon 16 as a cause of sporadic medullary thyroid carcinoma.
    Jindrichova S, Kodet R, Krskova L, Vlcek P, Bendlova B.
    J Mol Med (Berl); 2003 Dec 22; 81(12):819-23. PubMed ID: 14618242
    [Abstract] [Full Text] [Related]

  • 19. A complex nine base pair deletion in RET exon 11 common in sporadic medullary thyroid carcinoma.
    Alemi M, Lucas SD, Sällström JF, Bergholm U, Akerström G, Wilander E.
    Oncogene; 1997 May 01; 14(17):2041-5. PubMed ID: 9160884
    [Abstract] [Full Text] [Related]

  • 20. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
    Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Höppener JW, van Amstel HK, Romeo G.
    Nature; 1994 Jan 27; 367(6461):375-6. PubMed ID: 7906866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.